Unique biological activity of botulinum D/C mosaic neurotoxin in murine species

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2886-2893

  Nakamura, Keiji ^a   Kohda, Tomoko ^a   Shibata, Yuto ^b   Tsukamoto, Kentaro ^c   Arimitsu, Hideyuki ^c   Hayashi, Mitsunori ^b   Mukamoto, Masafumi ^a   Sasakawa, Nobuyuki ^b   Kozaki, Shunji ^a  

^a Osaka Prefecture University   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN C; BOTULINUM TOXIN D; BOTULINUM TOXIN DC; CHOLERA TOXIN B SUBUNIT; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOSIDE GT 1B; GLUTAMIC ACID; SYNAPTOBREVIN; SYNAPTOBREVIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMAFFIN CELL; CLOSTRIDIUM BOTULINUM TYPE C; CLOSTRIDIUM BOTULINUM TYPE D; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL GLANDS; ANIMALS; BOTULINUM TOXINS; CATTLE; CEREBELLUM; CHROMAFFIN CELLS; CLOSTRIDIUM BOTULINUM; FEMALE; GANGLIOSIDES; MICE; NEUROTOXINS; PC12 CELLS; PROTEIN BINDING; RATS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY;

EID: 84864812745     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00302-12     Document Type: Article

References (44)

1. Angstrom J, et al. 2000. Novel carbohydrate binding site recognizing blood group A and B determinants in a hybrid of cholera toxin and Escherichia coli heat-labile enterotoxin B-subunits. J. Biol. Chem. 275:3231- 3238.
2. Arimitsu H, et al. 2009. Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli. Protein Expr. Purif. 67:96 -103.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248 -254.
4. Chen C, Fu Z, Kim JJ, Barbieri JT, Baldwin MR. 2009. Gangliosides as high affinity receptors for tetanus neurotoxin. J. Biol. Chem. 284:26569- 26577.
5. Chen S, Hall C, Barbieri JT. 2008. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin. J. Biol. Chem. 283: 21153-21159.
6. Deak F, Shin OH, Kavalali ET, Sudhof TC. 2006. Structural determinants of synaptobrevin 2 function in synaptic vesicle fusion. J. Neurosci. 26:6668-6676.
7. Dertzbaugh MT, Cox LM. 1998. The affinity of cholera toxin for Ni2_ ion. Protein Eng. 11:577-581.
8. Dong M, et al. 2006. SV2 is the protein receptor for botulinum neurotoxin A. Science 312:592-596.
9. Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. 2009. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48:5631-5641.
10. Hoch DH, et al. 1985. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. U. S. A. 82:1692-1696.
11. Humeau Y, Doussau F, Grant NJ, Poulain B. 2000. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82:427- 446.
12. Iwamori M, Domino SE. 2004. Tissue-specific loss of fucosylated glycolipids in mice with targeted deletion of _(1,2) fucosyltransferase genes. Biochem. J. 380:75- 81.
13. Kroken AR, et al. 2011. Unique ganglioside binding by botulinum neurotoxins C and D-SA. FEBS J. 278:4486-4496.
14. Kroken AR, Karalewitz AP, Fu Z, Kim JJ, Barbieri JT. 2011. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. J. Biol. Chem. 286:26828 -26837.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Li JY, Edelmann L, Jahn R, Dahlstrom A. 1996. Axonal transport and distribution of synaptobrevin I and II in the rat peripheral nervous system. J. Neurosci. 16:137-147.
17. Liu Y, Sugiura Y, Lin W. 2011. The role of synaptobrevin1/VAMP1 in Ca2_-triggered neurotransmitter release at the mouse neuromuscular junction. J. Physiol. 589:1603-1618.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
19. Merritt EA, et al. 1995. Surprising leads for a cholera toxin receptorbinding antagonist: crystallographic studies of CTB mutants. Structure. 3:561-570.
20. Moriishi K, et al. 1996. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim. Biophys. Acta 1307:123-126.
21. Nakamura K, et al. 2010. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet. Microbiol. 140:147-154.
22. Nishiki T, et al. 1994. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269:10498 -10503.
23. Nishiki T, et al. 1996. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 378:253-257.
24. Norton WT, Abe T, Poduslo SE, DeVries GH. 1975. The lipid composition of isolated brain cells and axons. J. Neurosci. Res. 1:57-75.
25. Nuemket N, et al. 2011. Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: insight into the ganglioside binding mechanism. Biochem. Biophys. Res. Commun. 411: 433-439.
26. Nystuen AM, Schwendinger JK, Sachs AJ, Yang AW, Haider NB. 2007. A null mutation in VAMP1/synaptobrevin is associated with neurological defects and prewean mortality in the lethal-wasting mouse mutant. Neurogenetics 8:1-10.
27. Peng L, Tepp WH, Johnson EA, Dong M. 2011. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog. 7:e1002008. doi:10.1371/journal.ppat.1002008.
28. Raptis A, Torrejon-Escribano B, Gomez de Aranda I, Blasi J. 2005. Distribution of synaptobrevin/VAMP 1 and 2 in rat brain. J. Chem. Neuroanat. 30:201-211.
29. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493- 497.
30. Rizo J, Sudhof TC. 1998. Mechanics of membrane fusion. Nat. Struct. Biol. 10:839-842.
31. Sasakawa N, Murayama N, Kumakura K. 2005. Characterization of exocytotic events from single PC12 cells: amperometric studies in native PC12h, DA-loaded PC12h and bovine adrenal chromaffin cells. Cell. Mol. Neurobiol. 25:777-787.
32. Schiavo G, et al. 1992. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832- 835.
33. Schiavo G, et al. 1993. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268:23784- 23787.
34. Schmid MF, Robinson JP, DasGupta BR. 1993. Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles. Nature 364:827- 830.
35. Schmitt J, et al. 2010. Structural analysis of botulinum neurotoxin type G receptor binding. Biochemistry 49:5200 -5205.
36. Sekine M, et al. 1984. Ganglioside composition of chromaffin granule membrane in bovine adrenal medulla. J. Biochem. 95:155-160.
37. Sollner T, et al. 1993. SNAP receptors implicated in vesicle targeting and fusion. Nature 362:318 -324.
38. Stenmark P, Dupuy J, Imamura A, Kiso M, Stevens RC. 2008. Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog. 4:e1000129. doi:10.1371/journal.ppat.1000129.
39. Strotmeier J, et al. 2010. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Biochem. J. 431:207-216.
40. Takeda M, et al. 2005. Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis. 49:376 -381.
41. Torii Y, et al. 2010. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins. Toxicon 55:407- 414.
42. Tsukamoto K, et al. 2005. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 280:35164 -35171.
43. Yamasaki S, et al. 1994. Cleavage of members of the synaptobrevin/VAMP family by typesDand F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269:12764 -12772.
44. Yamashita T, et al. 2003. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. U. S. A. 100:3445-3449.